Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 27849-89-4
Drug Levels and Effects
Summary of Use during Lactation
Information in this record refers to the use of chromium Cr 51 edetate (Cr 51-ethylenediamine tetraacetic acid; Cr 51-EDTA) as a diagnostic agent for the estimation of glomerular filtration rate. The United States Nuclear Regulatory Commission and other international agencies state that breastfeeding need not be interrupted after administration of Cr 51 edetate 60 MBq (1.6 mCi) or less to a nursing mother.[1-3] However, to follow the principle of keeping exposure "as low as reasonably achievable", some experts recommend nursing the infant just before administration of the radiopharmaceutical and interrupting breastfeeding for 2 to 6 hours after the dose, then expressing the milk completely once and discarding it. If the mother has expressed and saved milk prior to the examination, she can feed it to the infant during the period of nursing interruption.[4-6]
Mothers concerned about the level of radioactivity in their milk could ask to have it tested at a nuclear medicine facility at their hospital. When the radioactivity is at a safe level, she may resume breastfeeding. A method for measuring milk radioactivity and determining the time when a mother can safely resume breastfeeding has been published.[7]
Drug Levels
Cr 51 is a gamma emitter with a principal photon energy of 320 keV and a physical half-life of 27.7 days. The effective half-life of Cr 51 edetate ranges from 5 to 11 hours, depending on kidney function.[4,7] and about 0.065% of an administered dose is excreted into breastmilk.[2]
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Mattsson S, Johansson L, Leide Svegborn S, et al. Radiation dose to patients from radiopharmaceuticals: A compendium of current information related to frequently used substances. ICRP Publication 128. Annex D. Recommendations on breast-feeding interruptions. Ann ICRP 2015;44 (2 Suppl):7-321. [PubMed: 26069086]
- 2.
- Leide-Svegborn S, Ahlgren L, Johansson L, Mattsson S. Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption. Eur J Nucl Med Mol Imaging 2016;43:808-21. [PubMed: 26732471]
- 3.
- Dilsizian V, Metter D, Palestro C, Zanzonico P. Advisory Committee on Medical Uses of Isotopes (ACMUI) Sub-Committee on Nursing Mother Guidelines for the Medical Administration of Radioactive Material. Final report submitted: January 31, 2019. 2019. https://www
.nrc.gov/docs /ML1903/ML19038A498.pdf - 4.
- Mountford PJ, Coakley AJ. A review of the secretion of radioactivity in human breast milk: Data, quantitative analysis and recommendations. Nucl Med Commun 1989;10:15-27. [PubMed: 2645546]
- 5.
- International Atomic Energy Agency. Radiation Protection and Safety in Medical Uses of Ionizing Radiation, IAEA Safety Standards Series No. SSG-46, IAEA, Vienna. 2018. https://www
.iaea.org /publications/11102/radiation-protection-and-safety-in-medical-uses-of-ionizing-radiation - 6.
- ARSAC notes for guidance: Good clinical practice in nuclear medicine. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. 2020. https://www
.gov.uk/government /publications /arsac-notes-for-guidance [PubMed: 10732169] - 7.
- Stabin MG, Breitz HB. Breast milk excretion of radiopharmaceuticals: Mechanisms, findings, and radiation dosimetry. J Nucl Med 2000;41:863-73. [PubMed: 10809203]
Substance Identification
Substance Name
Chromium Cr 51 Edetate
CAS Registry Number
27849-89-4
Drug Class
Breast Feeding
Lactation
Milk, Human
Radiopharmaceuticals
Chromium Radioisotopes
Diagnostic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Technetium Tc 99m Bicisate.[Drugs and Lactation Database (...]Review Technetium Tc 99m Bicisate.. Drugs and Lactation Database (LactMed®). 2006
- Review Technetium Tc 99m Glucoheptonate.[Drugs and Lactation Database (...]Review Technetium Tc 99m Glucoheptonate.. Drugs and Lactation Database (LactMed®). 2006
- Review Technegas.[Drugs and Lactation Database (...]Review Technegas.. Drugs and Lactation Database (LactMed®). 2006
- Review Technetium Tc 99m Pentetate.[Drugs and Lactation Database (...]Review Technetium Tc 99m Pentetate.. Drugs and Lactation Database (LactMed®). 2006
- Review Iodohippurate Sodium I 123.[Drugs and Lactation Database (...]Review Iodohippurate Sodium I 123.. Drugs and Lactation Database (LactMed®). 2006
- Chromium Cr 51 Edetate - Drugs and Lactation Database (LactMed®)Chromium Cr 51 Edetate - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...